Skip to main content
. 2022 Dec 10;15(12):1536. doi: 10.3390/ph15121536

Table 3.

Number of ICSRs without other suspected/interacting/concomitant drugs.

Statins Number of ICSRs That Do Not Mention Another Suspected Drug/Interacting Drug (%) Number of ICSRs That Do Not Mention Another Concomitant Drug (%)
Atorvastatin 1983 (54.20) 1765 (48.24)
Simvastatin 557 (23.95) 809 (34.78)
Rosuvastatin 845 (43.07) 764 (38.94)